{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:02:44Z","timestamp":1778940164375,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.bbadis.2020.166067","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T19:43:04Z","timestamp":1610134984000},"page":"166067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice"],"prefix":"10.1016","volume":"1867","author":[{"given":"Ester","family":"Gonzalez-Sanchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haquima","family":"El Mourabit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Clavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Moog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Vaquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Ledent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axelle","family":"Cadoret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie","family":"Gautheron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Fouassier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Wendum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Chignard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Housset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2020.166067_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bbadis.2020.166067_bb0010","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.23489","article-title":"Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C","volume":"51","author":"Petta","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0015","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jhep.2013.03.024","article-title":"Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease","volume":"59","author":"Trepo","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0020","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.dld.2018.12.022","article-title":"Association of vitamin D levels and vitamin D-related gene polymorphisms with liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"51","author":"Arai","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2020.166067_bb0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10620-018-5351-6","article-title":"Evolving role of vitamin D in immune-mediated disease and its implications in autoimmune hepatitis","volume":"64","author":"Czaja","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbadis.2020.166067_bb0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12072-014-9548-2","article-title":"Vitamin D modulates biliary fibrosis in ABCB4-deficient mice","volume":"8","author":"Hochrath","year":"2014","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.bbadis.2020.166067_bb0035","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0045","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0050","doi-asserted-by":"crossref","unstructured":"P. Fickert, M.J. Pollheimer, U. Beuers, C. Lackner, G. Hirschfield, C. Housset, V. Keitel, C. Schramm, H.U. Marschall, T.H. Karlsen, E. Melum, A. Kaser, B. Eksteen, M. Strazzabosco, M. Manns, M. Trauner, P.S.C.S.G. International, characterization of animal models for primary sclerosing cholangitis (PSC), Journal of Hepatology, 60 (2014) 1290\u20131303.","DOI":"10.1016\/j.jhep.2014.02.006"},{"key":"10.1016\/j.bbadis.2020.166067_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.07.011","article-title":"Multifunctional molecule ERp57: from cancer to neurodegenerative diseases","volume":"181","author":"Hettinghouse","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2020.166067_bb0060","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/jhep.2003.50176","article-title":"The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells","volume":"37","author":"Gascon-Barre","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0065","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.bbadis.2017.04.004","article-title":"Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis","volume":"1863","author":"Gonzalez-Sanchez","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bbadis.2020.166067_bb0070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0075","doi-asserted-by":"crossref","unstructured":"E. D'Aldebert, M.J. Biyeyeme Bi Mve, M. Mergey, D. Wendum, D. Firrincieli, A. Coilly, L. Fouassier, C. Corpechot, R. Poupon, C. Housset, N. Chignard, Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium, Gastroenterology, 136 (2009) 1435\u20131443.","DOI":"10.1053\/j.gastro.2008.12.040"},{"key":"10.1016\/j.bbadis.2020.166067_bb0080","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.26453","article-title":"Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice","volume":"58","author":"Firrincieli","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cell.2014.08.007","article-title":"Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy","volume":"159","author":"Sherman","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2020.166067_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","article-title":"A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues","volume":"112","author":"Jamall","year":"1981","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2020.166067_bb0095","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/hep4.1266","article-title":"Diet-induced dysbiosis and genetic background synergize with cystic fibrosis transmembrane conductance regulator deficiency to promote cholangiopathy in mice","volume":"2","author":"Debray","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.bbadis.2020.166067_bb0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jhep.2019.11.008","article-title":"Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease","volume":"72","author":"Majdi","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0105","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/0016-5085(93)90661-U","article-title":"Cl- and K+ transport in human biliary cell lines","volume":"104","author":"Basavappa","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0110","series-title":"Phosphatidylcholine passes by paracellular transport to the apical side of the polarized biliary tumor cell line Mz-ChA-1, International Journal of Molecular Sciences, 20","author":"Stremmel","year":"2019"},{"key":"10.1016\/j.bbadis.2020.166067_bb0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0120","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2353\/ajpath.2009.080079","article-title":"Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation","volume":"174","author":"Fouassier","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/gut.2009.186528","article-title":"Curcumin improves sclerosing cholangitis in Mdr2\u2212\/\u2212 mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation","volume":"59","author":"Baghdasaryan","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2020.166067_bb0130","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.30470","article-title":"Bile-derived organoids from patients with primary sclerosing cholangitis recapitulate their inflammatory immune profile","volume":"70","author":"Soroka","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2020.166067_bb0140","doi-asserted-by":"crossref","unstructured":"E.M. de Vries, M. de Krijger, M. Farkkila, J. Arola, P. Schirmacher, D. Gotthardt, B. Goeppert, P.J. Trivedi, G.M. Hirschfield, H. Ytting, B. Vainer, H.R. Buuren, K. Biermann, M.H. Harms, O. Chazouilleres, D. Wendum, A.D. Kemgang, R.W. Chapman, L.M. Wang, K.D. Williamson, A.S. Gouw, V. Paradis, C. Sempoux, U. Beuers, S.G. Hubscher, J. Verheij, C.Y. Ponsioen, Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: an international cohort study, Hepatology, 65 (2017) 907\u2013919.","DOI":"10.1002\/hep.28963"},{"key":"10.1016\/j.bbadis.2020.166067_bb0145","doi-asserted-by":"crossref","first-page":"G670","DOI":"10.1152\/ajpgi.00334.2013","article-title":"Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice","volume":"306","author":"Cai","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(\u2212\/\u2212) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/mol.114.097147","article-title":"1,25-dihydroxyvitamin D3 causes ADAM10-dependent ectodomain shedding of tumor necrosis factor receptor 1 in vascular smooth muscle cells","volume":"87","author":"Yang","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsbmb.2015.09.019","article-title":"Vitamin D-induced ectodomain shedding of TNF receptor 1 as a nongenomic action: D3 vs D2 derivatives","volume":"155","author":"Yang","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0165","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bone.2013.03.012","article-title":"Modeling hepatic osteodystrophy in Abcb4 deficient mice","volume":"55","author":"Hochrath","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bbadis.2020.166067_bb0170","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.30937","article-title":"Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice","volume":"71","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0175","doi-asserted-by":"crossref","first-page":"G208","DOI":"10.1152\/ajpgi.00398.2007","article-title":"Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier","volume":"294","author":"Kong","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0180","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41374-019-0310-1","article-title":"Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model","volume":"99","author":"Reiter","year":"2019","journal-title":"Laboratory Investigation; A Journal of Technical Methods and Pathology"},{"key":"10.1016\/j.bbadis.2020.166067_bb0185","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejphar.2016.07.052","article-title":"The vitamin D receptor agonist, calcipotriol, modulates fibrogenic pathways mitigating liver fibrosis in-vivo: an experimental study","volume":"789","author":"Wahsh","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fphar.2020.00200","article-title":"Calcipotriol inhibits NLRP3 signal through YAP1 activation to alleviate cholestatic liver injury and fibrosis","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2020.166067_bb0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbrc.2015.02.074","article-title":"1,25-(OH)(2)-vitamin D(3) prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4(\u2212\/\u2212) model","volume":"459","author":"Reiter","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2020.166067_bb0200","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/srep00535","article-title":"Diosgenin is an exogenous activator of 1,25D(3)-MARRS\/Pdia3\/ERp57 and improves Alzheimer\u2019s disease pathologies in 5XFAD mice","volume":"2","author":"Tohda","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2020.166067_bb0205","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.cellsig.2013.07.020","article-title":"Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1alpha,25(OH)(2)D(3)","volume":"25","author":"Chen","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2020.166067_bb0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jc.2014-2741","article-title":"The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients","volume":"100","author":"Petta","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2020.166067_bb0215","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/gutjnl-2014-307024","article-title":"Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stellate cells both receptor-dependently and independently","volume":"64","author":"Beilfuss","year":"2015","journal-title":"Gut"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443920304154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443920304154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:03:48Z","timestamp":1760418228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443920304154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0925443920304154"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2020.166067","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2020.166067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166067"}}